524663 Stock Overview
A biotechnology company, engages in the manufacture and sale of pharmaceutical products in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Bharat Immunologicals & Biologicals Corporation Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹27.44 |
| 52 Week High | ₹43.89 |
| 52 Week Low | ₹22.48 |
| Beta | 2.13 |
| 11 Month Change | -5.44% |
| 3 Month Change | -7.58% |
| 1 Year Change | 16.32% |
| 33 Year Change | -49.65% |
| 5 Year Change | 320.21% |
| Change since IPO | 101.32% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524663 | IN Biotechs | IN Market | |
|---|---|---|---|
| 7D | -7.1% | -3.8% | -2.6% |
| 1Y | 16.3% | 37.2% | 42.2% |
Return vs Industry: 524663 underperformed the Indian Biotechs industry which returned 37.2% over the past year.
Return vs Market: 524663 underperformed the Indian Market which returned 42.2% over the past year.
Price Volatility
| 524663 volatility | |
|---|---|
| 524663 Average Weekly Movement | 5.6% |
| Biotechs Industry Average Movement | 8.4% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.3% |
| 10% least volatile stocks in IN Market | 3.9% |
Stable Share Price: 524663 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 524663's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | n/a | Dhananjay Tiwary | bibcol.sciencecentral.in |
Bharat Immunologicals & Biologicals Corporation Limited, a biotechnology company, engages in the manufacture and sale of pharmaceutical products in India. It offers oral polio vaccines, zinc tablets, diarrhea management kits, and BIB sweet tablets. The company was incorporated in 1989 and is based in Bulandshahr, India.
Bharat Immunologicals & Biologicals Corporation Limited Fundamentals Summary
| 524663 fundamental statistics | |
|---|---|
| Market cap | ₹1.18b |
| Earnings (TTM) | -₹184.83m |
| Revenue (TTM) | ₹76.50m |
15.5x
P/S Ratio-6.4x
P/E RatioIs 524663 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524663 income statement (TTM) | |
|---|---|
| Revenue | ₹76.50m |
| Cost of Revenue | ₹67.76m |
| Gross Profit | ₹8.74m |
| Other Expenses | ₹193.57m |
| Earnings | -₹184.83m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -4.28 |
| Gross Margin | 11.43% |
| Net Profit Margin | -241.59% |
| Debt/Equity Ratio | 94.5% |
How did 524663 perform over the long term?
See historical performance and comparison